Author response to Cunha et al

Author response to Cunha et al

The need to identify biomarkers to predict immunotherapy response for rare cancers has been long overdue. We aimed to study this in our paper, ‘Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers’. In this response to the Letter to the Editor by Cunha et a...

Full description

Bibliographic Details
Main Authors: Vivek Subbiah, Sara Ahmed, Christian Rolfo, Aung Naing, Joud Hajjar, Bettzy Stephen, Jordi Rodon Ahnert, Daniel D Karp, Rivka R Colen, Murat Ak, Mira Ayoub, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O Zinn, Chaan Ng, Raghu Vikram, Spyridon Bakas, Christine B Peterson
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e003299.full

Internet

https://jitc.bmj.com/content/9/7/e003299.full

Similar Items